Biohaven Ltd. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -118.67M-213.80M-570.28M-408.17M-846.42M
Depreciation and Depletion 0.07M0.67M1.36M3.37M3.92M
Share-based Compensation 29.50M65.64M193.56M28.79M71.96M
Gains from Investment Securities 5.59M16.59M38.16M-33.30M11.70M
Cash from Operations -75.96M-145.84M-297.69M-331.73M-582.45M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.07M1.39M1.39M6.91M7.86M
Change in Working Capital
Change in Account Payables 0.22M1.02M5.93M4.87M0.71M
Change in Accured Expenses 14.86M9.82M6.80M-7.44M8.06M
Other Working Capital Changes 2.42M9.18M41.34M-27.18M-8.04M
Investing Activities
Capital Expenditures 1.10M0.94M6.07M3.05M4.05M
Acquisitions 1.88M0.39M
Change in Acquisitions & Divestments 322.08M504.36M
Cash from Investing Activities -2.70M0.94M-304.79M129.83M-244.97M
Financing Activities
Other financing activities 92.24M138.05M449.13M0.80M2.26M
Cash from Financing Activities 152.24M138.45M767.60M211.91M677.77M
Additional items
Exchange Rate Effect 0.43M-0.50M0.07M
Change in Cash 73.59M-6.45M165.55M9.52M-149.58M
Free Cash Flow -77.05M-146.78M-303.76M-334.77M-586.50M
Net Cash Flow 73.59M-6.45M165.12M10.01M-149.65M